PABLO DE LA
CUEVA DOBAO
Profesor asociado
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico Universitario Lozano Blesa (7)
2024
-
Efficacy of Risankizumab in Patients with Suboptimal Response or Failure to Ustekinumab: A Multicenter Retrospective Study in Spain
Dermatologic Therapy, Vol. 2024
-
Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study
Actas Dermo-Sifiliograficas
2021
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
2018
-
Redefining the therapeutic objective in psoriatic patients candidates for biological therapy
Journal of Dermatological Treatment, Vol. 29, Núm. 4, pp. 334-346
2016
-
Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert Recommendations
Actas Dermo-Sifiliograficas, Vol. 107, Núm. 3, pp. 194-206
-
Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert Recommendations
Actas dermo-sifiliograficas, Vol. 107, Núm. 3, pp. 194-206
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1